Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Health & Medicine
How J&J paved the way for Compass’ coming psychedelic drug launch
In an interview with BioPharma Dive, Compass executives said that, should the FDA approve their treatment, they hope to capitalize on a strategy pioneered by J&J in selling the ketamine spray…
Experts highlight regenerative medicine’s promise for women’s health
A scientific symposium organized by the Regenerative Medicine Society explored the latest research and applications of regenerative medicine in women’s reproductive health.
Chronic stress may be quietly reshaping your heart
Chronic inflammation tied to stress, lifestyle, mental health, and socioeconomic conditions may silently change the heart for years before any symptoms appear.